Form 8-K - Current report:
SEC Accession No. 0001437749-24-034910
Filing Date
2024-11-13
Accepted
2024-11-13 16:13:23
Documents
16
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20241113_8k.htm   iXBRL 8-K 28806
2 EXHIBIT 99.1 ex_747310.htm EX-99.1 96091
7 logosm.jpg GRAPHIC 12780
  Complete submission text file 0001437749-24-034910.txt   307400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20241112.xsd EX-101.SCH 3892
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20241112_def.xml EX-101.DEF 13827
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20241112_lab.xml EX-101.LAB 18219
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20241112_pre.xml EX-101.PRE 13859
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20241113_8k_htm.xml XML 4881
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241454364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)